Formulate Financial’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Sell
769
-8
-1% -$3.21K 0.31% 22
2026
Q1
$241K Sell
777
-147
-16% -$48.4K 0.3% 24
2025
Q4
$320K Buy
+924
New +$330K 0.38% 21

Other funds holding AVGO

Formulate Financial's AVGO Position: Q2 2026 in Review

Formulate Financial reduced its Broadcom (AVGO) stake by 1% in Q2 2026, selling an estimated $3.21K and leaving 769 shares worth $291K. The position accounts for 0.31% of the portfolio, ranked #22.

Formulate Financial first reported a position in AVGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $320K in Q4 2025. 3,167 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Formulate Financial held 769 shares of Broadcom worth $291K as of Q2 2026.
  • Formulate Financial sold 8 Broadcom shares in Q2 2026, an estimated $3.21K.
  • Broadcom made up 0.31% of Formulate Financial's portfolio in Q2 2026, its #22 holding.
  • Formulate Financial first reported a position in Broadcom in Q4 2025 and has held it in 3 quarters since.
  • Formulate Financial's Broadcom position peaked at $320K in Q4 2025.
  • 3,167 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Formulate Financial's 13F filing for Q2 2026, filed 31 Jul 2026.